Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 3, 2013, Pages 201-210

  Das, Undurti N ^a,b,c  

^a UND LIFE SCIENCES   (United States)

^b GAYATRI VIDYA PARISHAD COLLEGE OF ENGINEERING   (India)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Arachidonic acid; Beta cells; Diabetes mellitus; Inflammation; Lipoxin; Protectin; Resolvin

Indexed keywords

ARACHIDONIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; CD59 ANTIGEN; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FATTY ACID DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LINOLEIC ACID; LINOLENIC ACID; LIPOXIN; LIPOXIN A; MIGRATION INHIBITION FACTOR; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; RESOLVIN D1; RESOLVIN E1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ENCEPHALITIS; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID BLOOD LEVEL; FATTY ACID SYNTHESIS; FEEDBACK SYSTEM; HUMAN; HYPOTHALAMUS; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING;

ANIMALS; ARACHIDONIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR; DIABETES MELLITUS; FATTY ACIDS, UNSATURATED; HUMANS; HYPOTHALAMUS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIPOXINS; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84875392663     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.11.009     Document Type: Article

References (107)

1. Nielsen J.H. Affinity purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 1986, 29:63-67.
2. Dunger A., Cunningham J.M., Delaney C.A., et al. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned rat islets: extent of nitric oxide involvement. Diabetes 1996, 45:89-183.
3. Lukic M.L., Stosic-Grujicic S., Shahin A. Effector mechanisms in low-dose streptozotocin-induced diabetes. Dev. Immunol. 1998, 6:119-128.
4. Movahedi B., Van de Casteele M., Caluwe N., et al. Human pancreatic duct cells can produce tumour necrosis factor-alpha that damages neighbouring beta cells and activates dendritic cells. Diabetologia 2004, 47:998-1008.
5. Bojunga J., Kusterer K., Bacher M., et al. Macrophage migration inhibitory factor and development of type-1 diabetes in non-obese diabetic mice. Cytokine 2003, 21:179-186.
6. Hirokawa J., Sakaue S., Tagami S., et al. Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 1997, 235:94-98.
7. Hirokawa J., Sakaue S., Furuya Y., et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J. Biochem. (Tokyo) 1998, 123:733-739.
8. Das U.N. Is metabolic syndrome X an inflammatory condition?. Exp. Biol. Med. 2002, 227:97-989.
9. Das U.N. Is obesity an inflammatory condition?. Nutrition 2001, 17:66-953.
10. Visser M., Bouter L.M., McQuillan G.M., et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
11. Hotamisligil G.S. The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J. Internet Med. 1999, 245:621-625.
12. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
13. Das U.N., Padma M., Sagar P.S., et al. Stimulation of free radical generation in human leukocytes by various agents including tumor necrosis factor is a calmodulin dependent process. Biochem. Biophys. Res. Commun. 1990, 167:36-1030.
14. Mullen P.G., Windsor A.C., Walsh C.J., et al. Tumor necrosis factor-alpha and interleukin-6 selectively regulate neutrophil function in vitro. J. Surg. Res. 1995, 58:124-130.
15. Das U.N. Clinical laboratory tools to diagnose inflammation. Adv. Clin. Chem. 2006, 41:189-229.
16. Serhan C.N. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:141-162.
17. Claria J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Nat. Acad. Sci. U.S.A. 1995, 92:9475-9479.
18. Das U.N. Essential fatty acids Biochemistry, physiology, and pathology. Biotechnol. J. 2006, 1:420-439.
19. Serhan C.N., Hong S., Gronert K., Colgan S.P., Devchand P.R., Mirick G., Moussignac R.-L. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammatory signals. J. Exp. Med. 2002, 196:1025-1037.
20. Das U.N. Essential fatty acids- a review. Curr. Pharm. Biotechnol. 2006, 7:467-482.
21. Chiang N., Arita M., Serhan C.N. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:163-177.
22. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation signals in resolution. Nat. Immunol. 2001, 2:612-619.
23. Serhan C.N., Maddox J.F., Petasis N.A., Akritopoulou-Zanze I., Papayianni A., Brady H.R., Colgan S.P., Madara J.L. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 1995, 34:14609-14615.
24. Das U.N. Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation. J. Inflamm. Res. 2010, 3:143-170.
25. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Chiang N., Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 2000, 192:1197-1204.
26. Serhan C.N., Clish C.B., Brannon J., Colgan S.P., Gronert K., Chiang N. Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions. J. Physiol. Pharmacol. 2000, 51(4 Pt 1):643-654.
27. Lattin J.E., Schroder K., Su A.I., Walker J.R., Zhang J., Wiltshire T., Saijo K., Glass C.K., Hume D.A., Kellie S., Sweet M.J. Expression analysis of G protein-coupled receptors in mouse macrophages. Immunome Res. 2008, 4:5.
28. Milligan G., Stoddart L.A., Brown A.J. G protein-coupled receptors for free fatty acids. Cell. Signalling 2006, 18:1360-1365.
29. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., Li P., Lu W.J., Watkins S.M., Olefsky J.M. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
30. Katoh T., Lakkis F.G., Makita N., Badr K.F. Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4mRNAs in rat nephrotoxic nephritis. Kidney Int. 1994, 46:341-349.
31. Latour M.G., Alquier T., Oseid E., Tremblay C., Jetton TL, Luo J, DCH Lin, Poitout V GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Diabetes 2007, 56:1087-1094.
32. Kebede M., Alquier T., Latour M.G., Semache M., Tremblay C., Poitout V. The fatty acid receptor GPR40 plays a role in insulin secretion in vivo after high-fat feeding. Diabetes 2008, 57:2432-2437.
33. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., Fujino M. Free fatty acids regulate insulin secretion from pancreatic Β cells through GPR40. Nature 2003, 422:173-176.
34. Das U.N. Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?. Lipids Health Dis. 2008, 7:19.
35. Sodin-Semrl S., Taddeo B., Tseng D., Varga J., Fiore S. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 2000, 164:2660-2666.
36. Wu J., Wang A., Min Z., Xiong Y., Yan Q., Zhang J., Xu J., Zhang S. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by Β-amyloid in vitro and in vivo. Biochem. Biophys. Res. Commun. 2011, 408:382-387.
37. Börgeson E., Lönn J., Bergström I., Brodin V.P., Ramström S., Nayeri F., Särndahl E., Bengtsson T., Lipoxin A. inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression. Infect. Immun. 2011, 79:1489-1497.
38. Serhan C.N., Reardon E. 15-Hydroxyeicosatetraenoic acid inhibits superoxide anion generation by human neutrophils: relationship to lipoxin production. Free Radic. Res. Commun. 1989, 7:341-345.
39. Das U.N. Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?. Lipids Health Dis. 2008, 7:19.
40. Suresh Y., Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of ω-6 fatty acids. Nutrition 2003, 19:93-114.
41. Suresh Y., Das U.N. Long-chain polyunsaturated fatty acids and chemically-induced diabetes mellitus: effect of ω-3 fatty acids. Nutrition 2003, 19:213-228.
42. Suresh Y., Das U.N. Protective action of arachidonic acid against alloxan-induced cytotoxicity and diabetes mellitus. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64:37-52.
43. Harishankar N., Vajreswari A., Giridharan N.V. WNIN/GR-Ob-an insulin-resistant obese rat model from inbred WNIN strain. Indian J. Med. Res. 2011, 134:320-329.
44. Das U.N. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins Leukot. Essent. Fatty Acids 1995, 52:387-391.
45. Stene L.C., Joner G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am. J. Clin. Nutr. 2003, 78:1128-1134. Norwegian Childhood Diabetes Study Group.
46. Stene L.C., Ulriksen J., Magnus P., Joner G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000, 43:1093-1098.
47. Wei D., Li J., Shen M., Jia W., Chen N., Chen T., Su D., Tian H., Zheng S., Dai Y., Zhao A. Cellular production of n-3 PUFAs and reduction of n-6 to n-3 ratios in the pancreatic Β-Cells and islets enhance insulin secretion and confer protection against cytokine-induced cell death. Diabetes 2010, 59:471-478.
48. Bellenger J., Bellenger S., Bataille A., Massey K.A., Nicolaou A., Rialland M., Tessier C., Kang J.X., Narce M. High Pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 2011, 60:1090-1099.
49. Hellman J., Tang Y., Kosuri M., Bhatnagar A., Spite M. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 2011, 25:2399-2407.
50. Cao L., Lin E.-J.D., Cahill M.C., Wang C., Liu X., During M.J. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat. Med. 2009, 15:447-454.
51. Das U.N. Obesity: genes, brain, gut, and environment. Nutrition 2010, 26:459-473.
52. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C.J., Arnold J.T., Rapoport S.I., Bazinet R.P. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 2007, 12:36-46.
53. Wu A., Ying Z., Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
54. Santhanam A.V., Smith L.A., Katusic Z.S. Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke 2010, 41:350-356.
55. Umashankar V., Baarathi R., Kaviarasan K., Mohanlal J., Das U.N., Angayarkanni N. Agonistic effect of polyunsaturated fatty acids (PUFAs) and its metabolites on brain-derived neurotrophic factor (BDNF) through molecular docking simulation. Lipid Health Dis. 2012, 11:109.
56. Das U.N. Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids and their Metabolites 2010, Wiley-Blackwell Publishers, Ames, IA, USA.
57. Das U.N. Is metabolic syndrome X a disorder of the brain?. Curr. Nutr. Food Sci. 2008, 4:73-108.
58. Das U.N. Metabolic syndrome is a low-grade systemic inflammatory condition. Expert Rev. Endocrinol. Metab. 2010, 5:577-592.
59. Yang L., Hotamisligil G.S. Stressing the brain, fattening the body. Cell 2008, 135:20-22.
60. Velloso L.A., Araujo E.P., de Souza C.T. Diet-induced inflammation of the hypothalamus in obesity. Neuroimmunomodulation 2008, 15:189-193.
61. Wisse B.E., Schwartz M.W. Does hypothalamic inflammation cause obesity?. Cell Metab. 2009, 10:241-242.
62. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-4199.
63. Milanski M., Degasperi G., Coope A., Morari J., Denis R., et al. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J. Neurosci. 2009, 29:359-370.
64. Moraes J.C., Coope A., Morari J., Cintra D.E., Roman E.A., et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS One 2009, 4:e5045.
65. Zabolotny J.M., Kim Y.B., Welsh L.A., Kershaw E.E., Neel B.G., et al. Proteintyrosine phosphatase 1B expression is induced by inflammation in vivo. J. Biol. Chem. 2008, 283:4230-14241.
66. Zhang X., Zhang G., Zhang H., Karin M., Bai H., et al. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135:61-73.
67. Pimentel G.D., Lira F.S., Rosa J.C., Oliveira J.L., Losinskas-Hachul A.C., Souza G.I., das Graças T., do Carmo M., Santos R.V., de Mello M.T., Tufik S., Seelaender M., Oyama L.M., Oller do Nascimento C.M., Watanabe R.H., Ribeiro E.B., Pisani L.P. Intake of trans fatty acids during gestation and lactation leads to hypothalamic inflammation via TLR4/NFκBp65 signaling in adult offspring. J. Nutr. Biochem. 2012, 23:265-271.
68. Wong S.W., Kwon M.J., Choi A.M., Kim H.P., Nakahira K., Hwang D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 2009, 284:27384-27392.
69. Weatherill A.R., Lee J.Y., Zhao L., Lemay D.G., Youn H.S., Hwang D.H. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 2005, 174:5390-5397.
70. Lee J.Y., Plakidas A., Lee W.H., Heikkinen A., Chanmugam P., Bray G., Hwang D.H. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 2003, 44:479-486.
71. Lee J.Y., Zhao L., Youn H.S., Weatherill A.R., Tapping R., Feng L., Lee W.H., Fitzgerald K.A., Hwang D.H. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 2004, 279:16971-16979.
72. Lee J.Y., Ye J., Gao Z., Youn H.S., Lee W.H., Zhao L., Sizemore N., Hwang D.H. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 2003, 278:37041-37051.
73. Das U.N. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Med. Sci. Monit. 2007, 13:RA214-RA221.
74. Das U.N. Is type 2 diabetes mellitus a disorder of the brain?. Nutrition 2002, 18:667-672.
75. Milanski M., Arruda A.P., Coope A., Ignacio-Souza L.M., Nunez C.E., Roman E.A., Romanatto T., Pascol L.B., Caricilli A.M., Torosoni M.A., Prada P.O., Saad M.J., Velloso L.A. Inhibition of hypothalamic inflammation reverses diet-induced insulin resistance in the liver. Diabetes 2012, 61:1455-1462.
76. Bellenger J., Bellenger S., Bataille A., Massey K.A., Nicolaou A., Rialland M., Tessier C., Kang J.X., Narce M. High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 2011, 60:1090-1099.
77. Cinta D.E., Ropelle E.R., Moraes J.C., Pauli J.R., Morari J., de Souza C.T., Grimaldi R., Stahl M., Carvalheira J.B., Saad M.J., Velloso L.A. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS ONE 2012, 7:e30571.
78. Lockie S.H., Heppner K.M., Chaudhary N., Chabenne J.R., Morgan D.A., Veyrat-Durebex C., Ananthakrishnan G., Rohner-Jeanrenaud F., Drucker D.J., DiMarchi R., Rahmouni K., Oldfield B.J., Tschop M.H., Perez-Tilver D. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes 2012, 61:2753-2762.
79. Cao L., Lin E.-J.D., Cahill M.C., Wang C., Liu X., During M.J. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat. Med. 2009, 15:447-454.
80. Mayer K., Schmidt R., Muhly-Reinholz M., Bogeholz T., Gokorsch S., Grimminger F., Seeger W. In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNF-α impact of ω-3 and ω-6 fatty acids. J. Lipid Res. 2002, 43:944-951.
81. Sena N., Snyder S.H. Neurotrophin-mediated degradation of histone methyltransferase by S-nitrosylation cascade regulates neuronal differentiation. Proc. Nat. Acad. Sci. U.S.A. 2011, 108:20178-20183.
82. Chen J., Zacharek A., Zhang C., Jiang H., Li Y., Roberts C., Lu M., Kapke A., Chopp M. Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J. Neurosci. 2005, 25:2366-2375.
83. Meuchel L.W., Thompson M.A., Cassivi S.D., Pabelick C.M., Prakash Y.S. Neurotrophins induce nitric oxide generation in human pulmonary artery endothelial cells. Cardiovasc. Res. 2011, 91:668-676.
84. Ma Y.-T., Hsieh T., Forbes M.E., Johnson J.E., Frost D.O. BDNF injected into the superior colliculus reduces developmental retinal ganglion cell death. J. Neurosci. 1998, 18:2097-2107.
85. Ernst A.F., Gallo G., Letourneau P.C., McLoon S.C. Stabilization of growing retinal axons by the combined signaling of nitric oxide and brain-derived neurotrophic factor. J. Neurosci. 2000, 20:1458-1469.
86. Steinkamp M., Schulte N., Spaniol U., Pfulger C., Hartmann C., Kirsch J., von Boyen G. Brain derived neurotrophic factor inhibits apoptosis in enteric glia during gut inflammation. Med. Sci. Monit. 2012, 18:BR117-BR122.
87. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E.F., Kolbeck R., Hoppe E., Oropeza-Wekerle R.-L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 1999, 189:865-870.
88. Massey K.A., Zago W.M., Berg D.K. BDNF up-regulates α7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons. Mol Cell Neurosci. 2006, 33:381-388.
89. Zhou X., Nai Q., Chen M., Dittus J.D., Howard M.J., Margiotta J.F. Brain-derived neurotrophic factor and trkB signaling in parasympathetic neurons: relevance to regulating α7-containing nicotinic receptors and synaptic function. J. Neurosci. 2004, 24:4340-4350.
90. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.-C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001, 411:86-89.
91. Nakamura K., Martin K.C., Jackson J.K., Beppu K., Woo C.-W., Thiele C.J. Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells. Cancer Res. 2006, 66:4249-4255.
92. Williams A.G., Hargreaves A.C., Gunn-Moore F.J., Tavare J.M. Stimulation of neuropeptide Y gene expression by brain-derived neurotrophic factor requires both the phospholipase Cγ and Shc binding sites on its receptor. TrkB Biochem. J. 1998, 333:505-509.
93. Solum D.T., Handa R.J. Estrogen regulates the development of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus. J. Neurosci. 2002, 22:2650-2659.
94. Wu A., Ying Z., Gomez-Pinilla F.D.H.A. dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008, 155(3):751-759. August 26.
95. Wu A., Ying Z., Gomez-Pinilla F. The salutary effects of DHA dietary supplementation on cognition, neuroplasticity, and membrane homeostasis after brain trauma. J. Neurotrauma 2011, 28:2113-2122.
96. Wu A., Ying Z., Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21:1457-1467.
97. Cansev M., Wurtman R.J., Sakamoto T., Ulus I.H. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimers Dement. 2008, 4(1 Suppl 1):S153-S168.
98. Das U.N. Vagus nerve stimulation as a strategy to prevent and manage metabolic syndrome. Med. Hypotheses 2011, 76:429-433.
99. Das U.N. Molecular Basis of Health and Disease 2011, Springer, New York.
100. González-Périz A., Horrillo R., Ferré N., Gronert K., Dong B., Morán-Salvador E., Titos E., Martínez-Clemente M., López-Parra M., Arroyo V., Clària J. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 2009, 23:1946-1957.
101. Hellmann J., Tang Y., Kosuri M., Bhatnagar A., Spite M. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. FASEB J. 2011, 25:2399-2407.
102. Börgeson E., McGillicuddy F.C., Harford K.A., Corrigan N., Higgins D.F., Maderna P., Roche H.M., Godson C Lipoxin A4 attenuates adipose inflammation. FASEB J. 2012, 26:4287-4294.
103. Yamanaka M., Itakura Y., Tsuchida A., Nakagawa T., Taiji M. Brain-derived neurotrophic factor (BDNF) prevents the development of diabetes in prediabetic mice. Biomed. Res. 2008, 29:147-153.
104. Yamanaka M., Itakura Y., Ono-Kishino M., Tsuchida A., Nakagawa T., Taiji M. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice. J. Biosci. Bioeng. 2008, 105:395-402.
105. Nakagawa T., Tsuchida A., Itakura Y., Nonomura T., Ono M., Hirota F., Inoue T., Nakayama C., Taiji M., Noguchi H. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000, 49:436-444.
106. Sampson M.J., Gopaul N., Davies I.R., Hughes D.A., Carrier M.J. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2diabetes. Diabetes Care 2002, 25:537-541.
107. Gerber R.T., Holemans K., O'Brien-Coker I., Mallet A.I., van Bree R., Van Assche F.A., Poston L. Increase of the isoprostane 8-isoprostaglandin f2alpha in maternal and fetal blood of rats with streptozotocin-induced diabetes: evidence of lipid peroxidation. Am. J. Obstet. Gynecol. 2000, 183:1035-1040.